KANG; Keon Wook

Patent Applications and Registrations

Patent applications and USPTO patent grants for KANG; Keon Wook.The latest application filed is for "composition for preventing or treating allergic diseases containing mixed extract of two or more among asiasarum root, platycodon root, and cinnamomi ramulus as active ingredients".

Company Profile

4.4.14

KANG; Keon Wook - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition For Preventing Or Treating Allergic Diseases Containing Mixed Extract Of Two Or More Among Asiasarum Root, Platycodon Root, And Cinnamomi Ramulus As Active Ingredients App 20210338759 - YANG; Hyun Ok ; et al.	2021-11-04
Pharmaceutical Composition Comprising Tha As Effective Ingredient For Treatment Of Prostate Cancer App 20210093583 - KANG; Keon Wook ; et al.	2021-04-01
Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis Grant 10,639,320 - Kang , et al.	2020-05-05
Pharmaceutical Composition Comprising Tha As Active Ingredient For Treating Breast Cancer App 20190262281 - KANG; Keon Wook ; et al.	2019-08-29
Pharmaceutical Composition Containing Gpr119 Ligand As Effective Ingredient For Preventing Or Treating Non-alcoholic Steatohepatitis App 20190008864 - KANG; Keon Wook ; et al.	2019-01-10
Pharmaceutical composition for preventing or treating of cirrhosis of liver comprising G protein coupled receptor 119 ligand as an active ingredient Grant 9,895,370 - Kang , et al. February 20, 2	2018-02-20
Method for simultaneously detecting fluorescence and raman signals for multiple fluorescence and raman signal targets, and medical imaging device for simultaneously detecting multiple targets using the method Grant 9,833,145 - Jeong , et al. December 5, 2	2017-12-05
Pharmaceutical Composition Comprising Gold-containing Agent For Preventing Or Treating Liver Fibrosis Or Liver Cirrhosis App 20170266219 - Kang; Keon Wook ; et al.	2017-09-21
Pharmaceutical composition for preventing or treating of cirrhosis of liver comprising G protein coupled receptor 119 ligand as an active ingredient App 20170143714 - KANG; Keon Wook ; et al.	2017-05-25
Method For Simultaneously Detecting Fluorescence And Raman Signals For Multiple Fluorescence And Raman Signal Targets, And Medical Imaging Device For Simultaneously Detecting Multiple Targets Using The Method App 20170112380 - JEONG; Dae Hong ; et al.	2017-04-27
Pharmaceutical Composition Containing Gpr119 Ligand As Active Ingredient For Preventing Or Treating Non-alcoholic Fatty Liver Disease App 20170049773 - KANG; Keon Wook ; et al.	2017-02-23
Method For Simultaneously Detecting Fluorescence And Raman Signals For Multiple Fluorescence And Raman Signal Targets, And Medical Imaging Device For Simultaneously Detecting Multiple Targets Using The Method App 20130137944 - Jeong; Dae Hong ; et al.	2013-05-30
Kit For Diagnosis Of Breast Cancer Using Herceptin, A Composition Comprising Herceptin And A Method For Detecting Herceptin-sensitive Her2 Overexpressed Cell Using The Same App 20100316635 - Lee; Eun Sook ; et al.	2010-12-16
Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis Grant 7,078,045 - Kim , et al. July 18, 2	2006-07-18
Pharmaceutical composition for regeneration of cirrhotic liver App 20060063781 - Kim; Sang-Geon ; et al.	2006-03-23
Pharmaceutical composition for regeneration of cirrhotic liver App 20030171382 - Kim, Sang-Geon ; et al.	2003-09-11
Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis App 20030161877 - Kim, Sang-Geon ; et al.	2003-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.